A single-cell transcriptomic study found that RARRES2 (Retinoic Acid Receptor Responder 2) is the most downregulated gene in brain-metastatic TNBC tumors compared to primary breast tumors [102]. This evidence concerns the gene RARRES2 and breast neoplasm.